A carregar...

CDK4/6 Inhibition in Breast Cancer: Mechanisms of Response and Treatment Failure

PURPOSE OF REVIEW: To describe the role of D-type cyclins and CDKs 4 and 6 in breast cancer, and to discuss potential biomarkers for sensitivity or resistance to CDK4/6 inhibitors. RECENT FINDINGS: A small number of preclinical and clinical studies have explored potential mechanisms of CDK4/6 inhibi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Breast Cancer Rep
Main Authors: Garrido-Castro, Ana C., Goel, Shom
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5414585/
https://ncbi.nlm.nih.gov/pubmed/28479958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12609-017-0232-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!